High Risk Smoldering Multiple Myeloma
7 clinical trials · Condition
◉ Watch High Risk Smoldering Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| DARA RVD For High Risk SMM (NCT04775550) | Omar Nadeem, MD | 2021-03-08 |
| Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients (NCT02943473) | Icahn School of Medicine at Mount Sinai | 2017-05-18 |
| Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study (NCT02697383) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
| A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma (NCT01484275) | Janssen Research & Development, LLC | 2012-03-01 |
Track High Risk Smoldering Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.